Kroeger Christopher A.
- SEC CIK
- 0001658918
In the past year, 5 open-market sale filings worth $12.5M and no purchases.
Current role at each company
- MPLT MapLight Therapeutics, Inc.Chief Executive Officeras of Aug 19, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $12.5M
- 5 filings
- Net
- −$12.5M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Kroeger Christopher A. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 17, 2026 (view filing)9:46 PM ET | Jul 15-17 | 2 days | Kroeger Christopher A.Chief Executive Officer | SSaleVoting Common Stock | −147.6K | $36.87 | −$5.44M | −10.6%1.25M after | 7 lots |
| May 18, 2026 (view filing) | May 18 | Same day | Kroeger Christopher A.Chief Executive Officer | SSaleVoting Common Stock | −118.2K | $27.19 | −$3.21M | −7.8%1.39M after | 2 lots10b5-1 |
| May 11, 2026 (view filing) | May 7-11 | 4 days | Kroeger Christopher A.Chief Executive Officer | SSaleVoting Common Stock | −68.5K | $28.47 | −$1.95M | −4.3%1.51M after | 9 lots10b5-1 |
| May 6, 2026 (view filing) | May 4-6 | 2 days | Kroeger Christopher A.Chief Executive Officer | SSaleVoting Common Stock | −49.7K | $28.39 | −$1.41M | −3.1%1.58M after | 8 lots10b5-1 |
| Apr 17, 2026 (view filing) | Apr 15-16 | 2 days | Kroeger Christopher A.Chief Executive Officer | SSaleVoting Common Stock | −19.2K | $27.16 | −$521.1K | −1.2%1.63M after | 3 lots |